Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
28/08/2026 14:15
BRIEF-Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center Aug 28 (Reuters) - Vivos Therapeutics Inc VVOS.O:
VIVOS THERAPEUTICS AND SOUTH PALM CARDIOVASCULAR ASSOCIATES SIGN DEFINITIVE AGREEMENTS TO LAUNCH REGIONAL SLEEP TESTING AND TREATMENT CENTER
VIVOS THERAPEUTICS - EXPECTS TO HOLD 75% MAJORITY INTEREST IN AIM FLORIDA
VIVOS THERAPEUTICS - CENTER EXPECTED TO BEGIN TREATING PATIENTS AND GENERATING REVENUE IN Q1 2027
Source text: ID:nGNX9bYsKC
Further company coverage: VVOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth